ENTERO HEALTHCARE IPO NEWS
At $4.2 billion, Q2 2024 IPO size records its highest growth in 2 years
QIPs saw a rise in both value and volume compared to the previous quarter, with 20 issues raising $2.3 billion. This marks the second-highest volume since Q4 2017. The retail and consumer sector led deal activity, with an 18% increase in value over Q1 2024, despite a 7% decrease in volume.
Health insurer Niva Bupa, Sagility India files draft papers with Sebi for IPOs
The IPO, with each share having a face value of Rs 10, consists of a fresh issuance worth Rs 800 crore and an offer for sale totaling up to Rs 2,200 crore by the promoters and existing investors. As part of the OFS, Bupa Singapore Holdings and Fettle Tone will be divesting their stakes.
Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival
Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds raised as fresh issues in 2024 were to either finance capital assets or retire existing debt obtained to build capacities, according to IPO documents.
73% IPOs trading above issue price as primary market shines in H1, four turn multibaggers
The fundraising of Rs 26,272 crore, however fell short of the previous two years likely due to the absence of mega issues. Investors' reception also remained positive with only one failed IPO.
Insurer Niva Bupa plans $360 million IPO: Report
British United Provident Association (Bupa), which holds a 63% stake in the Indian venture, plans to sell a small stake worth up to $38 million and Indian private equity firm True North is planning a stake sale worth up to $225 million, the document detailing the IPO plans showed.
3C IT Solutions IPO opens today: Check issue size, price band, GMP and other details
The SME IPO of 3C IT Solutions will open today, aiming to raise Rs 11.44 crore. India's GII ranking improved to 40th position, making it a top offshoring destination for IT companies. Kreo Capital is the lead manager for the IPO.
- Go To Page 1
Indegene IPO booked over 10x so far on Day 3. Check subscription, GMP and other details
Indegene IPO GMP: On the final day of the initial public offer (IPO), Indegene was booked a little over 10 times so far on Wednesday, the last day of the bidding process.
Hot Stocks: Brokerages on RIL, Entero Healthcare, Natco Pharma and Persistent Systems
Brokerage Nomura upheld a neutral rating on Persistent Systems, while Investec continues to advocate a buy stance on Natco Pharma and has initiated a buy recommendation on Entero Healthcare. Conversely, CLSA has downgraded RIL to an outperform rating.
Shares worth $21 billion to enter market in 4 months as IPO lock-in period expires for 66 companies
66 companies are set to see the lock-in period for pre-listing shareholders lifted between March 4 and June 29. This amounts to $21.1 billion in value terms. The value pertains to the total lock-up opening shares, but not all the shares may be sold, as a sizable portion is also held by promoters and group entities
GPT Healthcare IPO to open on Thursday. What GMP signals ahead of subscription?
GPT Healthcare has fixed a price band of Rs 177-186 per share for its Rs 525-crore IPO. The issue closes on February 26. Investors can make bids for 80 shares in one lot and multiples thereafter. The proceeds will be used for prepayment or repayment of all or a portion of certain outstanding borrowings availed by the company and for general corporate purposes.
IPO calendar: 4 new issues, 7 listings to drive primary market activity next week
In the upcoming week, mainboard IPOs of Juniper Hotels and GPT Healthcare will hit the street to raise over Rs 2,000 crore. Meanwhile, SME companies Zenith Drugs and Dream Roll Tech are also scheduled to launch their issues.
Kolkata-based GPT Healthcare announces IPO dates. Check details
The IPO, with a face value of Rs 10, consists of a fresh issue of equity shares, aggregating to Rs 40 crore, and an offer for sale (OFS) of up to 2.6 crore equity shares by BanyanTree Growth Capital II, LLC, a Mauritius-based structured private equity.
Entero Healthcare sees negative listing. Should investors exit?
Entero has incurred losses in the past three fiscal years, raising concerns about its financial sustainability and profitability. It also faces challenges with negative cash flows from all three major activities, impacting working capital requirements.
Entero Healthcare Solutions shares list at 2% discount to IPO price
Entero Healthcare's IPO debuted with a discount on BSE and NSE. Proceeds will be used for debt repayment, working capital, funding subsidiaries, and inorganic growth. The company has 73 warehouses and supply relationships with over 1,900 healthcare product manufacturers. The target addressable market is valued at Rs 2.7 lakh crore.
Stocks in news: Entero Healthcare, YES Bank, Alpex Solar, Max Financial, UPL
Global private equity major Carlyle Group on Thursday sold 1.4% stake in private sector lender YES Bank for approximately Rs 1,057 crore.
Entero Healthcare shares to list on Friday. What GMP signals ahead of D-St debut
In the unlisted market, the company's shares are trading with a marginal premium of Rs 2, which indicates a flat or even a discounted debut at the bourses. The IPO comprised a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares.
Entero Healthcare Solutions IPO allotment: Check status, GMP, listing date and other details
To check the status of Entero Healthcare Solutions allotment through the registrar, which is Bigshare Services in this case, kindly follow the below steps.
Entero Healthcare IPO fully subscribed on final day. Check subscription, GMP and other details
Entero Healthcare IPO comprises a fresh equity issue of Rs 1,000 crore and an OFS of up to 47.69 lakh shares. Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, and Deepesh T Gala, among others, will offload shares under the OFS. The shares are trading with a marginal premium of Rs 10 in the grey market.
Entero Healthcare IPO sees tepid response. Check subscription, GMP, and other details
Entero Healthcare IPO price band has been fixed from Rs 1,195-1258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. the shares are trading with a marginal premium of Rs 5 in the grey market.
Entero Healthcare is going to expand more into tier II, tier III cities now
"In the last three years, our average annual growth rate has been 36% and once the IPO proceeds and we receive that money, we will be even more aggressive in terms of pursuing growth opportunities. In terms of business mix, 95% is coming from distribution services, but we also provide a lot of value-added services to these companies in terms of providing marketing and promotion services as well but that contributes less than 5% of our business as of now."
Massive growth opportunities for healthcare industry in India: Entero Healthcare MD
“Our business model is very simple. We are one of the largest distributors of healthcare products in this country. Basically, we buy from 1900 different companies today and supply to around eighty-one-and-a-half thousand retail pharmacies and three-and-a-half thousand hospitals.”
IPO Calendar: Primary market to breathe easy with only 2 IPOs scheduled next week
The Street will see a flurry of listings, four of them in the mainboard segment. Three IPOs of Rashi Peripherals, Jana SFB and Capital SFB opened last week and closed for subscription. The listings of these three public offers are scheduled for next week.
ETIG IPO Analysis: Entero Healthcare may Offer Better Value Post Listing
Incorporated in 2018 and founded by a former chief executive of Alkem Laboratories, Mumbai-based Entero Healthcare Solutions has grown to be among India's top three pharma distribution companies.
Entero Healthcare IPO: Should you subscribe to this Rs 1600 crore issue?
Entero Healthcare recorded a 31% YoY increase in revenue from operations during FY23, reaching Rs 3,300 crore. ICICI Securities, Dam Capital Advisors, Jefferies India, JM Financial, and SBI Capital Markets are the book running lead managers for the IPO.
Entero Healthcare's Rs 1,600-cr IPO biggest so far in 2024: 10 things to know before subscribing to the issue
The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Entero Healthcare announces dates, price band for its Rs 1,600-cr IPO
Entero Healthcare IPO: The price band has been fixed in the range of Rs 1,195-1,258 per equity share. Bids can be made for a minimum of 11 shares and in multiples thereafter. The IPO comprises a fresh equity issue of Rs 1,000 crore and an offer for sale of up to 47.69 lakh shares. Under the OFS, Prabhat Agrawal, Prem Sethi, Orbimed Asia Iii Mauritius, Chethan MP, Deepesh T Gala, among others, will offload shares.
Sebi gives nod for four IPOs
Healthcare products distributors Entero Healthcare's IPO consists of a fresh issue of ₹1,000 crore and an offer for sale of 85.57 lakh shares. Prabhat Agrawal, OrbiMed Asia III Mauritius, and Prem Sethi are among the investors selling shares in the OFS.
Four companies get Sebi's nod to launch IPOs
These four firms, which had filed their preliminary papers with the markets watchdog between June and October, obtained observation letters on January 16-19, an update with the Securities and Exchange Board of India (Sebi) showed on Thursday.
Entero gets Sebi nod for IPO
The Company’s initial public offering comprises a fresh issue of up to Rs 1000 crore and an offer for sale of up to 8,557,597 equity shares.
Load More
